 | • レポートコード：GIR201104127 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、末期腎臓病治療の世界市場を調査対象にし、末期腎臓病治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：BLR Bio LLC、Novartis AG、CTI BioPharma Corp、F. Hoffmann-La Roche Ltd、VESSL Therapeutics Ltd、Prolong Pharmaceuticals LLC ・メーカー別販売量、売上、市場シェア ・末期腎臓病治療の地域別市場分析 ・末期腎臓病治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・末期腎臓病治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・末期腎臓病治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・末期腎臓病治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・末期腎臓病治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・末期腎臓病治療の種類別市場規模2015-2020：MK-3866、パクリチニブ、サンギネート、テシドルマブ、その他 ・末期腎臓病治療の用途別市場規模2015-2020：クリニック、病院、その他 ・末期腎臓病治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global End-Stage Kidney Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The End-Stage Kidney Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
End-Stage Kidney Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, End-Stage Kidney Disease Treatment market has been segmented into
MK-3866
Pacritinib
Sanguinate
Tesidolumab
Others
By Application, End-Stage Kidney Disease Treatment has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global End-Stage Kidney Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level End-Stage Kidney Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global End-Stage Kidney Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the End-Stage Kidney Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and End-Stage Kidney Disease Treatment Market Share Analysis
End-Stage Kidney Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, End-Stage Kidney Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the End-Stage Kidney Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in End-Stage Kidney Disease Treatment are:
BLR Bio LLC
Novartis AG
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
VESSL Therapeutics Ltd
Prolong Pharmaceuticals LLC
Among other players domestic and global, End-Stage Kidney Disease Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe End-Stage Kidney Disease Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of End-Stage Kidney Disease Treatment, with price, sales, revenue and global market share of End-Stage Kidney Disease Treatment in 2018 and 2019.
Chapter 3, the End-Stage Kidney Disease Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the End-Stage Kidney Disease Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, End-Stage Kidney Disease Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe End-Stage Kidney Disease Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 End-Stage Kidney Disease Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global End-Stage Kidney Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 MK-3866
1.2.3 Pacritinib
1.2.4 Sanguinate
1.2.5 Tesidolumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global End-Stage Kidney Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global End-Stage Kidney Disease Treatment Market
1.4.1 Global End-Stage Kidney Disease Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BLR Bio LLC
2.1.1 BLR Bio LLC Details
2.1.2 BLR Bio LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BLR Bio LLC SWOT Analysis
2.1.4 BLR Bio LLC Product and Services
2.1.5 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CTI BioPharma Corp
2.3.1 CTI BioPharma Corp Details
2.3.2 CTI BioPharma Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CTI BioPharma Corp SWOT Analysis
2.3.4 CTI BioPharma Corp Product and Services
2.3.5 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche Ltd
2.4.1 F. Hoffmann-La Roche Ltd Details
2.4.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.4.4 F. Hoffmann-La Roche Ltd Product and Services
2.4.5 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 VESSL Therapeutics Ltd
2.5.1 VESSL Therapeutics Ltd Details
2.5.2 VESSL Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 VESSL Therapeutics Ltd SWOT Analysis
2.5.4 VESSL Therapeutics Ltd Product and Services
2.5.5 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Prolong Pharmaceuticals LLC
2.6.1 Prolong Pharmaceuticals LLC Details
2.6.2 Prolong Pharmaceuticals LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Prolong Pharmaceuticals LLC SWOT Analysis
2.6.4 Prolong Pharmaceuticals LLC Product and Services
2.6.5 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global End-Stage Kidney Disease Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global End-Stage Kidney Disease Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 End-Stage Kidney Disease Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 End-Stage Kidney Disease Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global End-Stage Kidney Disease Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global End-Stage Kidney Disease Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
4.3 Europe End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
4.5 South America End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Country
5.1.1 North America End-Stage Kidney Disease Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America End-Stage Kidney Disease Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
5.3 Canada End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe End-Stage Kidney Disease Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe End-Stage Kidney Disease Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
6.3 UK End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
6.4 France End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
6.5 Russia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
6.6 Italy End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific End-Stage Kidney Disease Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific End-Stage Kidney Disease Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7.3 Japan End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7.4 Korea End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7.5 India End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
7.7 Australia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Country
8.1.1 South America End-Stage Kidney Disease Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America End-Stage Kidney Disease Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa End-Stage Kidney Disease Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa End-Stage Kidney Disease Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa End-Stage Kidney Disease Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global End-Stage Kidney Disease Treatment Sales and Market Share by Type (2015-2020)
10.2 Global End-Stage Kidney Disease Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global End-Stage Kidney Disease Treatment Price by Type (2015-2020)
11 Global End-Stage Kidney Disease Treatment Market Segment by Application
11.1 Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2015-2020)
11.2 Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2015-2020)
11.3 Global End-Stage Kidney Disease Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global End-Stage Kidney Disease Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 End-Stage Kidney Disease Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America End-Stage Kidney Disease Treatment Market Forecast (2021-2025)
12.2.2 Europe End-Stage Kidney Disease Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific End-Stage Kidney Disease Treatment Market Forecast (2021-2025)
12.2.4 South America End-Stage Kidney Disease Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa End-Stage Kidney Disease Treatment Market Forecast (2021-2025)
12.3 End-Stage Kidney Disease Treatment Market Forecast by Type (2021-2025)
12.3.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global End-Stage Kidney Disease Treatment Market Share Forecast by Type (2021-2025)
12.4 End-Stage Kidney Disease Treatment Market Forecast by Application (2021-2025)
12.4.1 Global End-Stage Kidney Disease Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global End-Stage Kidney Disease Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global End-Stage Kidney Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of End-Stage Kidney Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global End-Stage Kidney Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. BLR Bio LLC Basic Information, Manufacturing Base and Competitors
Table 8. BLR Bio LLC End-Stage Kidney Disease Treatment Major Business
Table 9. BLR Bio LLC End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 10. BLR Bio LLC SWOT Analysis
Table 11. BLR Bio LLC End-Stage Kidney Disease Treatment Product and Services
Table 12. BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG End-Stage Kidney Disease Treatment Major Business
Table 15. Novartis AG End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 16. Novartis AG SWOT Analysis
Table 17. Novartis AG End-Stage Kidney Disease Treatment Product and Services
Table 18. Novartis AG End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. CTI BioPharma Corp Basic Information, Manufacturing Base and Competitors
Table 20. CTI BioPharma Corp End-Stage Kidney Disease Treatment Major Business
Table 21. CTI BioPharma Corp End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 22. CTI BioPharma Corp SWOT Analysis
Table 23. CTI BioPharma Corp End-Stage Kidney Disease Treatment Product and Services
Table 24. CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 26. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Major Business
Table 27. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 28. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 29. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product and Services
Table 30. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. VESSL Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 32. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Major Business
Table 33. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 34. VESSL Therapeutics Ltd SWOT Analysis
Table 35. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product and Services
Table 36. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Prolong Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 38. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Major Business
Table 39. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 40. Prolong Pharmaceuticals LLC SWOT Analysis
Table 41. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product and Services
Table 42. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global End-Stage Kidney Disease Treatment Sales by Manufacturer (2018-2019) (K Pcs)
Table 44. Global End-Stage Kidney Disease Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global End-Stage Kidney Disease Treatment Sales by Regions (2015-2020) (K Pcs)
Table 46. Global End-Stage Kidney Disease Treatment Sales Market Share by Regions (2015-2020)
Table 47. Global End-Stage Kidney Disease Treatment Revenue by Regions (2015-2020) (USD Million)
Table 48. North America End-Stage Kidney Disease Treatment Sales by Countries (2015-2020) (K Pcs)
Table 49. North America End-Stage Kidney Disease Treatment Sales Market Share by Countries (2015-2020)
Table 50. North America End-Stage Kidney Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 51. North America End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 52. Europe End-Stage Kidney Disease Treatment Sales by Countries (2015-2020) (K Pcs)
Table 53. Europe End-Stage Kidney Disease Treatment Sales Market Share by Countries (2015-2020)
Table 54. Europe End-Stage Kidney Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific End-Stage Kidney Disease Treatment Sales by Regions (2015-2020) (K Pcs)
Table 56. Asia-Pacific End-Stage Kidney Disease Treatment Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific End-Stage Kidney Disease Treatment Revenue by Regions (2015-2020) (USD Million)
Table 58. South America End-Stage Kidney Disease Treatment Sales by Countries (2015-2020) (K Pcs)
Table 59. South America End-Stage Kidney Disease Treatment Sales Market Share by Countries (2015-2020)
Table 60. South America End-Stage Kidney Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 61. South America End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa End-Stage Kidney Disease Treatment Sales by Countries (2015-2020) (K Pcs)
Table 63. Middle East & Africa End-Stage Kidney Disease Treatment Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa End-Stage Kidney Disease Treatment Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 66. Global End-Stage Kidney Disease Treatment Sales by Type (2015-2020) (K Pcs)
Table 67. Global End-Stage Kidney Disease Treatment Sales Share by Type (2015-2020)
Table 68. Global End-Stage Kidney Disease Treatment Revenue by Type (2015-2020) (USD Million)
Table 69. Global End-Stage Kidney Disease Treatment Revenue Share by Type (2015-2020)
Table 70. Global End-Stage Kidney Disease Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Global End-Stage Kidney Disease Treatment Sales Share by Application (2015-2020)
Table 72. Global End-Stage Kidney Disease Treatment Sales Forecast by Regions (2021-2025) (K Pcs)
Table 73. Global End-Stage Kidney Disease Treatment Market Share Forecast by Regions (2021-2025)
Table 74. Global End-Stage Kidney Disease Treatment Sales Forecast by Type (2021-2025) (K Pcs)
Table 75. Global End-Stage Kidney Disease Treatment Market Share Forecast by Type (2021-2025)
Table 76. Global End-Stage Kidney Disease Treatment Sales Forecast by Application (2021-2025)
Table 77. Global End-Stage Kidney Disease Treatment Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. End-Stage Kidney Disease Treatment Picture
Figure 2. Global Sales Market Share of End-Stage Kidney Disease Treatment by Type in 2019
Figure 3. MK-3866 Picture
Figure 4. Pacritinib Picture
Figure 5. Sanguinate Picture
Figure 6. Tesidolumab Picture
Figure 7. Others Picture
Figure 8. End-Stage Kidney Disease Treatment Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global End-Stage Kidney Disease Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey End-Stage Kidney Disease Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global End-Stage Kidney Disease Treatment Sales Market Share by Manufacturer in 2019
Figure 33. Global End-Stage Kidney Disease Treatment Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 End-Stage Kidney Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 End-Stage Kidney Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global End-Stage Kidney Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 40. Global End-Stage Kidney Disease Treatment Revenue Market Share by Regions in 2018
Figure 41. North America End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
Figure 42. Europe End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
Figure 44. South America End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020)
Figure 46. North America End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America End-Stage Kidney Disease Treatment Sales Market Share by Countries (2015-2020)
Figure 48. North America End-Stage Kidney Disease Treatment Sales Market Share by Countries in 2018
Figure 49. North America End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America End-Stage Kidney Disease Treatment Revenue Market Share by Countries in 2018
Figure 51. United States End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Countries in 2019
Figure 57. Germany End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific End-Stage Kidney Disease Treatment Sales Market Share by Regions 2019
Figure 64. Asia-Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Regions 2019
Figure 65. China End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America End-Stage Kidney Disease Treatment Sales Market Share by Countries in 2019
Figure 72. South America End-Stage Kidney Disease Treatment Revenue Market Share by Countries in 2019
Figure 73. Brazil End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa End-Stage Kidney Disease Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa End-Stage Kidney Disease Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global End-Stage Kidney Disease Treatment Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global End-Stage Kidney Disease Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales End-Stage Kidney Disease Treatment Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales End-Stage Kidney Disease Treatment Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales End-Stage Kidney Disease Treatment Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales End-Stage Kidney Disease Treatment Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales End-Stage Kidney Disease Treatment Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
腎臓移植拒絶治療の世界市場 2020年 Market Overview The global Kidney Transplant Rejection Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidn…- カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …
- スマートパワーステージ（SPS）モジュールの世界市場 2020年 Market Overview The Smart Power Stage (SPS) Modules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 高速単段遠心送風機の世界市場 2020年 Market Overview The High-Speed Single-stage Centrifugal Blower market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…